<3907> Silconsta 816 -24

Falling. After the trading on the 10th, the company announced a downward revision of its full-year financial estimates for the fiscal year ending November 24, leading to a dominant selling trend. Revenue is 442.4 billion yen (3.8% decrease compared to previous forecast), operating profit is 14.8 billion yen (41.7% decrease), and ordinary profit is 13.1 billion yen (48.6% decrease), providing a sudden forecast of declining profits. The factors include a decrease in commissioned development of gaming environment development contracts, temporal decrease in revenue through subsidiary business structural reform, and particularly a significant decline in talent introduction business due to the sudden decrease in adoption enthusiasm of gaming companies.

<5577> Idemi 1079 -101

Significant drop. After the close of trading on the 10th, the performance for the first quarter of the fiscal year ending in May 2025 was announced, leading to a sell-off. Operating loss was 27,464 million yen, ordinary loss was 28,087 million yen, and quarterly net loss attributable to the parent company's shareholders fell into the red at 36,238 million yen. Factors such as the acquisition of elusive stocks, holding large-scale marketing events for corporate clients, and actively promoting upfront investments such as hiring personnel in anticipation of medium-term growth are cited as reasons.

<4017> Creema 260 -14

Continued decline. After the close of trading on the 10th, the performance for the second quarter of the fiscal year ending in February 2025 was announced, which was met with selling pressure. Operating profit decreased significantly by 63% year-on-year to 0.016 billion yen. However, this was due to the recognition of event-related grant income in the same period of the previous year, with revenue increasing by 101% year-on-year to 1.248 billion yen, and operating profit showing a strong increase of 342% to 0.016 billion yen.

<7409> AeroEdge 2273 +400

Hitting the upper limit. After the trading on the 10th, the company announced the signing of a long-term contract with a global major aircraft manufacturer for component supply, which has been well received. This contract is a long-term agreement with a global major aircraft manufacturer abroad for the company to manufacture and sell commercial aircraft-related parts. Based on this contract, the company plans to supply a certain proportion of the contract parts necessary for the production of related aircraft parts throughout the contract period. Additionally, aiming to achieve mass production of other aircraft-related parts besides LEAP engines to expand the business portfolio.

<7066> Piaz 795 +29

Surging. The company announced the share buyback after the closing of the 10th trade, which led to a sharp rebound. The upper limit of the shares that can be acquired is 0.25 million shares (2.6% of the total number of issued shares excluding treasury shares) or 0.2 billion yen. The acquisition period is from October 15 to April 14, 25. The company considers share buybacks as an option for shareholder returns in addition to dividends, taking into account the current market price of the shares and financial conditions comprehensively, and aims to implement a flexible capital policy in response to the business environment.

<4593> Helios 205 0

After a morning high, the price recedes. The announcement of achieving milestones and demand forecasts based on a joint research contract with AND medical group for the utilization of cultured supernatants, which is seen as positive news. Following the achievement of the first milestone based on the progress of research in the joint research contract with AND medical aimed at utilizing the culture supernatant produced in the process of producing regenerative medical products owned by the company, a temporary payment of 60 million yen, followed by receiving 60 million yen as compensation for the milestone, is scheduled to be deposited in the fourth quarter of the fiscal year ending December 2024.